ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB,...
10
Transcript of ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB,...
![Page 1: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/1.jpg)
![Page 2: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/2.jpg)
![Page 3: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/3.jpg)
![Page 4: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/4.jpg)
![Page 5: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/5.jpg)
![Page 6: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/6.jpg)
![Page 7: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/7.jpg)
![Page 8: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/8.jpg)
![Page 9: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/9.jpg)
![Page 10: ubmm.med.buffalo.edu Palmitate0001.pdf · placebos (20% Intralipid , 200 mg/mL; Fresenius Kabi AB, Uppsala, Sweden) that did not require reconstitution or refriger- ation. Deltoid](https://reader030.fdocuments.in/reader030/viewer/2022040104/5e8ac58fc52bbd624a547324/html5/thumbnails/10.jpg)